Medical Device | May 20, 2026
Boston Scientific invests $1.5 billion in MiRus for TAVR expansion
Deal includes exclusive option to acquire MiRus’ SIEGEL TAVR system for an additional $3 billion upon milestone achievements
Deal includes exclusive option to acquire MiRus’ SIEGEL TAVR system for an additional $3 billion upon milestone achievements
Growth was broad-based across segments
Penumbra projects fourth-quarter revenue growth of 21.4% to 22.0%, with full-year 2025 revenue expected to reach approximately $1.4 billion
The PharmaEssentia Innovation Research Center (PIRC) will advance the company’s diverse pipeline and research footprint in the U.S., driving job creation
The centre will initially employ 170 engineers, bringing the total number of Boston Scientific’s R&D employees in India to more than 300
The transaction is anticipated to close in the first quarter of 2022
Highlights potential for at-home heart attack risk assessment, offering a new approach to reducing treatment delays
The country’s strength lies not just in technology availability but in adoption behaviour
Health innovations are viewed more positively than food and agricultural technologies
Move comes amid rising regulatory pressures
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
